We Ran A Stock Scan For Earnings Growth And Blue Jet Healthcare (NSE:BLUEJET) Passed With Ease
May 01
Have your own idea? Try our Stock Screener
Indian (NIFTY) Pharma Industry Analysis
UpdatedMay 06, 2025
DataAggregated Company Financials
Companies170
- 7D-0.9%
- 3M-0.7%
- 1Y12.9%
- YTD-8.3%
Last week, the Pharma industry hasn't moved much but Abbott India is up 3.4% in that time. As for the the longer term, the industry is up 12% over the past 12 months. Looking forward, earnings are forecast to grow by 16% annually.
Industry Valuation and Performance
Has the Indian Pharma Industry valuation changed over the past few years?
| Date | Market Cap | Revenue | Earnings | PE | Absolute PE | PS |
|---|---|---|---|---|---|---|
| Tue, 06 May 2025 | ₹19.7t | ₹3.9t | ₹563.0b | 29.8x | 35x | 5.1x |
| Thu, 03 Apr 2025 | ₹19.2t | ₹3.9t | ₹559.4b | 29.5x | 34.4x | 4.9x |
| Sat, 01 Mar 2025 | ₹18.0t | ₹3.9t | ₹561.5b | 25.8x | 32.1x | 4.6x |
| Mon, 27 Jan 2025 | ₹19.9t | ₹3.8t | ₹531.6b | 31.6x | 37.5x | 5.2x |
| Wed, 25 Dec 2024 | ₹20.8t | ₹3.8t | ₹526.7b | 34.8x | 39.4x | 5.5x |
| Fri, 22 Nov 2024 | ₹20.1t | ₹3.8t | ₹526.7b | 31.6x | 38.1x | 5.3x |
| Sun, 20 Oct 2024 | ₹21.4t | ₹3.7t | ₹492.6b | 40.1x | 43.4x | 5.7x |
| Tue, 17 Sep 2024 | ₹21.7t | ₹3.7t | ₹492.6b | 42.6x | 44.1x | 5.8x |
| Thu, 15 Aug 2024 | ₹20.2t | ₹3.8t | ₹489.0b | 35x | 41.4x | 5.4x |
| Sat, 13 Jul 2024 | ₹18.6t | ₹3.6t | ₹449.9b | 35x | 41.4x | 5.2x |
| Mon, 10 Jun 2024 | ₹17.4t | ₹3.6t | ₹448.1b | 32.7x | 38.8x | 4.9x |
| Wed, 08 May 2024 | ₹16.9t | ₹3.5t | ₹420.1b | 34.3x | 40.1x | 4.8x |
| Fri, 05 Apr 2024 | ₹17.1t | ₹3.5t | ₹418.9b | 33.5x | 40.9x | 4.9x |
| Sun, 03 Mar 2024 | ₹16.9t | ₹3.5t | ₹418.7b | 33.2x | 40.4x | 4.9x |
| Tue, 30 Jan 2024 | ₹15.9t | ₹3.4t | ₹396.1b | 34.8x | 40.2x | 4.7x |
| Thu, 28 Dec 2023 | ₹14.8t | ₹3.4t | ₹395.2b | 32.8x | 37.5x | 4.4x |
| Sat, 25 Nov 2023 | ₹14.0t | ₹3.4t | ₹395.1b | 31x | 35.6x | 4.2x |
| Mon, 23 Oct 2023 | ₹13.1t | ₹3.3t | ₹368.0b | 29.8x | 35.6x | 4x |
| Wed, 20 Sep 2023 | ₹13.3t | ₹3.3t | ₹369.5b | 30.3x | 35.9x | 4.1x |
| Fri, 18 Aug 2023 | ₹13.1t | ₹3.3t | ₹367.0b | 28.7x | 35.6x | 4x |
| Sun, 16 Jul 2023 | ₹11.9t | ₹3.2t | ₹342.6b | 26.3x | 34.9x | 3.8x |
| Tue, 13 Jun 2023 | ₹11.0t | ₹3.2t | ₹342.4b | 25.8x | 32.1x | 3.5x |
| Thu, 11 May 2023 | ₹10.6t | ₹3.1t | ₹297.8b | 27.2x | 35.5x | 3.4x |
| Sat, 08 Apr 2023 | ₹9.8t | ₹3.0t | ₹277.5b | 24.5x | 35.2x | 3.3x |
| Mon, 06 Mar 2023 | ₹9.4t | ₹3.0t | ₹277.5b | 23x | 33.9x | 3.1x |
| Wed, 01 Feb 2023 | ₹9.7t | ₹2.9t | ₹284.5b | 25.5x | 34.1x | 3.3x |
| Fri, 30 Dec 2022 | ₹9.9t | ₹2.9t | ₹274.9b | 26.7x | 36x | 3.5x |
| Sun, 27 Nov 2022 | ₹10.1t | ₹2.9t | ₹274.9b | 26.9x | 36.8x | 3.5x |
| Tue, 25 Oct 2022 | ₹10.1t | ₹2.8t | ₹259.9b | 23.9x | 38.9x | 3.6x |
| Thu, 22 Sep 2022 | ₹9.7t | ₹2.8t | ₹261.9b | 23.4x | 36.9x | 3.5x |
| Sat, 20 Aug 2022 | ₹9.8t | ₹2.8t | ₹261.9b | 22.3x | 37.3x | 3.5x |
| Mon, 18 Jul 2022 | ₹9.7t | ₹2.8t | ₹274.6b | 21.6x | 35.2x | 3.5x |
| Wed, 15 Jun 2022 | ₹9.2t | ₹2.8t | ₹273.8b | 20.7x | 33.7x | 3.3x |
| Fri, 13 May 2022 | ₹9.2t | ₹2.7t | ₹334.9b | 20.4x | 27.5x | 3.4x |
Price to Earnings Ratio
27.5x
Current Industry PE
- Investors are relatively neutral on the Indian Pharmaceuticals industry at the moment, indicating that they anticipate long term growth rates to remain steady.
- The industry is trading close to its 3-year average PE ratio of 37.0x.
- The 3-year average PS ratio of 4.3x is lower than the industry's current PS ratio of 5.0x.
Past Earnings Growth
- The earnings for companies in the Pharmaceuticals industry have grown 19% per year over the last three years.
- Revenues for these companies have grown 13% per year.
- This means that more sales are being generated by these companies overall, and subsequently their profits are increasing too.
Industry Trends
Which industries have driven the changes within the Indian Healthcare industry?
| IN Market | 0.21% | |
| Healthcare | -0.43% | |
| Pharma | -0.88% | |
| Pharma | -0.88% | |
Industry PEThere are no additional sub-industries under this industry.
Forecasted GrowthThere are no additional sub-industries under this industry.
Top Stock Gainers and Losers
Which companies have driven the market over the last 7 days?
| Company | Last Price | 7D | 1Y | Valuation | |
|---|---|---|---|---|---|
| 500488 Abbott India | ₹30.77k | 3.4% +₹21.8b | 19.5% | PE49x | |
| 500660 GlaxoSmithKline Pharmaceuticals | ₹2.89k | 1.6% +₹7.7b | 39.3% | PE57.1x | |
| AMIORG Ami Organics | ₹1.20k | 8.4% +₹7.6b | 100.0% | PE62x | |
| ALKEM Alkem Laboratories | ₹5.09k | 1.2% +₹7.1b | -1.2% | PE28.2x | |
| APLLTD Alembic Pharmaceuticals | ₹905.45 | 4.0% +₹6.8b | -11.6% | PE29.4x |
